82 related articles for article (PubMed ID: 21528284)
1. VLA(3)/integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
Garcia S; Bergeret D; Martini F; Andrac L; Horschowski N; Choux R; Levaut M; Charpin C
Int J Oncol; 1997 Oct; 11(4):849-56. PubMed ID: 21528284
[TBL] [Abstract][Full Text] [Related]
2. VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
Charpin C; Garcia S; Bergeret D; Andrac L; Horschowski N; Choux R; Lavaut MN
Br J Cancer; 1998 Jun; 77(12):2274-80. PubMed ID: 9649145
[TBL] [Abstract][Full Text] [Related]
3. ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.
Charpin C; Bergeret D; Garcia S; Andrac L; Martini F; Horschowski N; Choux R; Lavaut MN
Int J Oncol; 1998 May; 12(5):1041-8. PubMed ID: 9538126
[TBL] [Abstract][Full Text] [Related]
4. VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Andrac L; Horschowski N; Choux R; Lavaut MN
Hum Pathol; 1998 Sep; 29(9):896-903. PubMed ID: 9744304
[TBL] [Abstract][Full Text] [Related]
5. Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Lavaut MN; Allasia C
Br J Cancer; 1997; 76(3):340-6. PubMed ID: 9252201
[TBL] [Abstract][Full Text] [Related]
6. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.
Charpin C; Devictor B; Bergeret D; Andrac L; Boulat J; Horschowski N; Lavaut MN; Piana L
Am J Clin Pathol; 1995 Apr; 103(4):443-8. PubMed ID: 7726141
[TBL] [Abstract][Full Text] [Related]
7. bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Clin Oncol; 1998 Jun; 16(6):2025-31. PubMed ID: 9626199
[TBL] [Abstract][Full Text] [Related]
8. Quantitative imaging of ps2 immunocytochemical assays in breast carcinomas.
Charpin C; Devictor B; Bonnier P; Andrac L; Boulat J; Lavaut M; Allasia C; Piana L
Int J Oncol; 1993 Mar; 2(3):443-8. PubMed ID: 21573575
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin quantitative immunocytochemical assays in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Choux R; Lavaut M
J Pathol; 1997 Mar; 181(3):294-300. PubMed ID: 9155715
[TBL] [Abstract][Full Text] [Related]
10. Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Choux R; Lavaut MN; Allasia C
Hum Pathol; 1997 Mar; 28(3):289-96. PubMed ID: 9042792
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.
Charpin C; Garcia S; Bouvier C; Martini F; Lavaut M; Allasia C; Bonnier P; Andrac L
J Clin Pathol; 1997 Jul; 50(7):586-90. PubMed ID: 9306940
[TBL] [Abstract][Full Text] [Related]
12. CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up.
Charpin C; Garcia S; Bouvier C; Martini F; Andrac L; Bonnier P; Lavaut MN; Allasia C
Am J Clin Pathol; 1997 May; 107(5):534-41. PubMed ID: 9128265
[TBL] [Abstract][Full Text] [Related]
13. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
[TBL] [Abstract][Full Text] [Related]
14. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
15. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data.
Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR.
Charpin C; Bonnier P; Khouzami A; Vacheret H; Andrac L; Lavaut MN; Allasia C; Piana L
Anticancer Res; 1992; 12(3):591-7. PubMed ID: 1352440
[TBL] [Abstract][Full Text] [Related]
17. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
18. Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.
Koretz K; Schlag P; Boumsell L; Möller P
Am J Pathol; 1991 Mar; 138(3):741-50. PubMed ID: 2000944
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of Ki 67/MIB1 automated and quantitative immunolabelling in primary operable breast carcinomas.
Charpin C; Garcia S; Bouvier C; Devictor B; Andra L; Lavaut M; Allasia C; Bonnier P
Int J Oncol; 1996 Aug; 9(2):337-44. PubMed ID: 21541520
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
